COVID-19 Vaccine Multiple Sclerosis Survey Study - Participants with and without MS

STUDY BASICS

Researchers at the University of Pittsburgh are seeking adults with and without a diagnosis of multiple sclerosis or other neuroinflammatory disease for a survey study to help understand your feelings about the COVID-19 vaccine. Participants in this research study may or may not have already received the COVID-19 vaccine. Participation involves completing multiple surveys over one year

STUDY PURPOSE

People who have multiple sclerosis (MS) or other neuroinflammatory diseases may have different experiences and concerns related to COVID-19 vaccines compared to people without these types of conditions. The purpose of this survey study is to better understand how people with and without MS (or a related disorder such as neuromyelitis optica spectrum disorder or MOG-antibody mediated disease) feel about the COVID-19 vaccine. Researchers hope their findings lead to a better understanding of how the COVID-19 vaccine impacts people with underlying neuroinflammatory diseases.

COULD THIS STUDY BE RIGHT FOR YOU?

• Ages 18 and up
• Participants may or may not have a diagnosis of multiple sclerosis or another neuroinflammatory disease (ex., neuromyelitis optica spectrum disorder, MOG-antibody mediated disease)
• Participants may or may not have already received the COVID-19 vaccine/may or may not plan to receive the COVID-19 vaccine

WHAT PARTICIPANTS CAN EXPECT

Participation takes place entirely online. A survey will be sent to you once every 3 months over the course of the next year. The questions you are asked with each survey will depend on your vaccination status.